These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8393423)
1. Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells. Yano H; Iemura A; Fukuda K; Mizoguchi A; Haramaki M; Kojiro M Hepatology; 1993 Aug; 18(2):320-7. PubMed ID: 8393423 [TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 in human hepatocellular carcinoma cell lines. Haramaki M; Yano H; Fukuda K; Momosaki S; Ogasawara S; Kojiro M Hepatology; 1995 May; 21(5):1276-84. PubMed ID: 7537711 [TBL] [Abstract][Full Text] [Related]
3. A new human hepatocellular carcinoma cell line (HAK-2) forms various structures in collagen gel matrices. Haramaki M; Yano H; Iemura A; Momosaki S; Ogasawara S; Inoue M; Yamaguchi R; Kusaba A; Utsunomiya I; Kojiro M Hum Cell; 1997 Sep; 10(3):183-92. PubMed ID: 9436038 [TBL] [Abstract][Full Text] [Related]
4. Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells. Nakayama M; Ogasawara S; Akiba J; Ueda K; Koura K; Todoroki K; Kinoshita H; Yano H J Gastroenterol Hepatol; 2014 May; 29(5):1092-101. PubMed ID: 24325739 [TBL] [Abstract][Full Text] [Related]
5. Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma. Itoh T; Shiro T; Seki T; Nakagawa T; Wakabayashi M; Inoue K; Okamura A Int J Mol Med; 2000 Aug; 6(2):137-42. PubMed ID: 10891556 [TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of two cell lines derived from a single hepatocellular carcinoma containing multiploid DNA distribution. Chiu JH; Chang HM; Kao HL; Wu LH; Lui WY Cancer Detect Prev; 1996; 20(1):43-51. PubMed ID: 8907202 [TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062 [TBL] [Abstract][Full Text] [Related]
8. Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas. Ariizumi S; Takasaki K; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S Hepatogastroenterology; 2004; 51(56):500-4. PubMed ID: 15086191 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465 [TBL] [Abstract][Full Text] [Related]
10. Pathology of early hepatocellular carcinoma: progression from early to advanced. Kojiro M; Yano H; Nakashima O Semin Surg Oncol; 1996; 12(3):197-203. PubMed ID: 8727611 [TBL] [Abstract][Full Text] [Related]
11. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma]. Qin L; Tang Z; Liu K Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987 [TBL] [Abstract][Full Text] [Related]
12. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751 [TBL] [Abstract][Full Text] [Related]
13. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Hsu HC; Cheng W; Lai PL Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521 [TBL] [Abstract][Full Text] [Related]
14. Pathology of early hepatocellular carcinoma: progression from early to advanced. Kojiro M Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1203-5. PubMed ID: 9730375 [TBL] [Abstract][Full Text] [Related]
15. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
16. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations. Kubicka S; Trautwein C; Niehof M; Manns M Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249. Oguey D; Dumenco LL; Pierce RH; Fausto N Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370 [TBL] [Abstract][Full Text] [Related]
18. 'Nodule-in-nodule' appearance in hepatocellular carcinoma: its significance as a morphologic marker of dedifferentiation. Kojiro M Intervirology; 2004; 47(3-5):179-83. PubMed ID: 15383727 [TBL] [Abstract][Full Text] [Related]
19. Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma. Midorikawa Y; Tsutsumi S; Nishimura K; Kamimura N; Kano M; Sakamoto H; Makuuchi M; Aburatani H Cancer Res; 2004 Oct; 64(20):7263-70. PubMed ID: 15492245 [TBL] [Abstract][Full Text] [Related]